According to our (Global Info Research) latest study, the global Medical Continuous Glucose Monitor (CGM) market size was valued at US$ 7447 million in 2025 and is forecast to a readjusted size of US$ 17426 million by 2032 with a CAGR of 13.0% during review period.
Medical Continuous Glucose Monitor is a regulated wearable glucose sensing system intended for medical use in diabetes care that continuously estimates glucose levels and provides trends and alerts that support therapy decisions under clinician and patient use. It typically consists of a disposable sensor worn on the body, an electronics module that captures and transmits signals, and software algorithms that convert signals into glucose readings and alerts designed to meet medical performance, safety, and cybersecurity requirements under applicable regulatory and quality standards. The unit price of a Medical Continuous Glucose Monitor (CGM) typically ranges from tens to hundreds of dollars, with industry gross margins generally between 40% and 60%.
Upstream, the supply chain depends on specialized biosensor components and high-control manufacturing inputs, including enzyme and membrane chemistries, microfabricated electrodes, biocompatible polymers and adhesives, miniature electronics, wireless modules, batteries, sterilization services, and high-integrity packaging, all supported by rigorous quality systems and traceability. Midstream, medical CGM manufacturers integrate sensor production with firmware, mobile applications, cloud infrastructure, cybersecurity, clinical validation, and regulatory compliance, while building high-volume assembly, calibration, and reliability testing capabilities to maintain low defect rates. Downstream, products flow through prescription and reimbursement-driven channels such as pharmacies and durable medical equipment providers, with demand shaped by clinician prescribing, payer coverage policies, patient training and support services, and integration with insulin pumps, smart pens, and clinical software platforms that use CGM data for dosing decisions, remote monitoring, and long-term diabetes management.
The Medical Continuous Glucose Monitor market is moving from a specialist device category into a core infrastructure layer for diabetes management, with competition increasingly defined by clinical reliability at scale rather than feature checklists. As payers and providers broaden access to larger Type 2 populations, the winning platforms will be those that deliver consistent accuracy across real-world conditions, low failure rates, and actionable insights that fit routine clinical workflows. The market is also becoming more system-oriented, where interoperability with insulin delivery, decision support software, and electronic health records can lock in user and provider preference over time. Price pressure and reimbursement scrutiny will intensify as volumes rise, pushing manufacturers to improve manufacturing yields, reduce per-day sensor cost, and build robust service models that minimize discontinuation. Overall, category leaders should continue to consolidate share through ecosystem advantages and evidence generation, while challengers face high barriers in regulatory validation, manufacturing quality, and post-market performance management.
This report is a detailed and comprehensive analysis for global Medical Continuous Glucose Monitor (CGM) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Medical Continuous Glucose Monitor (CGM) market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Medical Continuous Glucose Monitor (CGM) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Medical Continuous Glucose Monitor (CGM) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Medical Continuous Glucose Monitor (CGM) market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Medical Continuous Glucose Monitor (CGM)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Medical Continuous Glucose Monitor (CGM) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Medtronic, Dexcom, I-SENS, Senseonics, Sinocare, MicroTech Medical, POCTech, Meiqi Medical Equipment, Medtrum Technologies, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Medical Continuous Glucose Monitor (CGM) market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Non-Invasive Monitoring
Invasive Monitoring
Market segment by Replacement Mechanism
Replaceable Type
Long-term Retention Type
Market segment by Intelligence
Basic Type
Intelligent Type
Market segment by Application
Hospitals
Clinics
Others
Major players covered
Abbott
Medtronic
Dexcom
I-SENS
Senseonics
Sinocare
MicroTech Medical
POCTech
Meiqi Medical Equipment
Medtrum Technologies
SIBIONICS
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Medical Continuous Glucose Monitor (CGM) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Medical Continuous Glucose Monitor (CGM), with price, sales quantity, revenue, and global market share of Medical Continuous Glucose Monitor (CGM) from 2021 to 2026.
Chapter 3, the Medical Continuous Glucose Monitor (CGM) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Medical Continuous Glucose Monitor (CGM) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Medical Continuous Glucose Monitor (CGM) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Medical Continuous Glucose Monitor (CGM).
Chapter 14 and 15, to describe Medical Continuous Glucose Monitor (CGM) sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Medical Continuous Glucose Monitor (CGM). Industry analysis & Market Report on Medical Continuous Glucose Monitor (CGM) is a syndicated market report, published as Global Medical Continuous Glucose Monitor (CGM) Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Medical Continuous Glucose Monitor (CGM) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.